血C4d水平与多发性狼性炎的治疗反应和活动相关
Agneta Zickert1,2, Caroline Grönwall1, Anna Juto1,2
1Department of Medicine Solna, Division of Rheumatology, Center for Molecular Medicine, Stockholm, Sweden.
Rheumatology (Oxford, England)
|April 25, 2025
概括
像C4d这样的补充标志物表明狼性炎 (LN) 的治疗成功. 随访活检中的C4d水平与增殖性LN的临床和组织学改善相关,但C4基因变异不会影响治疗反应.
科学领域:
- 腎臟病學 (nephrology) 是一種醫學專業.
- 免疫学 免疫学 免疫学
- 遗传学 遗传学 是一个
背景情况:
- 狼性炎 (LN) 是系统性红斑狼的一种严重并发症.
- 补体系统的激活在LN病变发生中起着至关重要的作用.
- 预测LN的治疗反应仍然是一个临床挑战.
研究的目的:
- 为了研究狼性炎 (LN) 患者的补充因子 (C3,C4,C4d).
- 评估补充水平,治疗反应和C4基因变异之间的关系.
- 为了确定在LN的治疗疗效的潜在生物标志物.
主要方法:
- 对77名活跃的LN患者进行分析,在免疫抑制治疗前后对细胞活检.
- 测量血清补充因子C3,C4,C4d和C4d/C4比率.
- 对C4基因拷贝数变异 (C4A和C4B) 的研究.
主要成果:
- 补充因子水平 (C3,C4,C4d) 在治疗后发生显著变化,特别是在对治疗有反应的增殖性LN (PLN) 患者中.
- 随访活检中的C4d和C4d/C4比率与临床和组织病理学反应有很强的相关性.
- 升高的C4d和C4d/C4水平与持续的活动有关,而C4基因变异没有影响治疗结果.
结论:
- 补充标记物,特别是C4d,受到免疫抑制疗法的影响,并且与LN的治疗反应相关.
- 随访活检中的C4d和C4d/C4比率显示为预测治疗成功的生物标志物具有前途.
- 在这一群LN患者中,C4遗传变异似乎不会影响C4水平或治疗反应.
相关概念视频
Factors Affecting Renal Clearance: Renal Impairment
30
Renal dysfunction significantly impairs the renal clearance of drugs, leading to potential complications in drug therapy. Renal failure, which can be caused by various factors, poses a significant challenge in the elimination of drugs from the body.
One condition associated with renal failure is uremia. Uremia is characterized by impaired glomerular filtration and fluid accumulation in the body. This condition hinders the renal clearance of drugs, resulting in drug accumulation and potential...
One condition associated with renal failure is uremia. Uremia is characterized by impaired glomerular filtration and fluid accumulation in the body. This condition hinders the renal clearance of drugs, resulting in drug accumulation and potential...
30
Renal Failure: Dose Adjustments
35
In patients with renal impairment, drugs undergo significant changes in their pharmacokinetics, which require dosage adjustments to ensure safe and effective therapy.
Reduced renal clearance and elimination rate are common outcomes of renal impairment. These alterations lead to a prolonged elimination half-life and an altered apparent volume of distribution for drugs. As a result, dosage adjustments are typically necessary to maintain optimal drug levels in the body.
However, dosage adjustments...
Reduced renal clearance and elimination rate are common outcomes of renal impairment. These alterations lead to a prolonged elimination half-life and an altered apparent volume of distribution for drugs. As a result, dosage adjustments are typically necessary to maintain optimal drug levels in the body.
However, dosage adjustments...
35
Renal Corpuscle
1.2K
The glomerulus and Bowman's capsule are two essential components of the nephron, which is the functional unit of the kidney. These microscopic structures play a critical role in the process of blood filtration to produce urine.
Glomerulus: Structure and Function
The glomerulus is a tiny, intricate network of capillaries located at the beginning of the nephron. It's enveloped by the Bowman's capsule and receives its blood supply from an afferent arteriole, which divides into numerous...
Glomerulus: Structure and Function
The glomerulus is a tiny, intricate network of capillaries located at the beginning of the nephron. It's enveloped by the Bowman's capsule and receives its blood supply from an afferent arteriole, which divides into numerous...
1.2K
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers
37
Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
37


